drugset / Trial / NCT02962258

BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

NCT02962258

Phase 1 Completed 34 enrolled Torrent Pharmaceuticals Limited
RandomizedCrossoverOpen-labelTreatment

Summary

Subjects to compare the single dose bioavailability of Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets 40+10+25 mg and Tribenzor® 40+10+25 mg Tablets of Daichi Sankyo Inc, USA. Dosing periods of studies were separated by a washout period of 22 days.

Timeline

Start
2011-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Hydrochlorothiazide Unknown 25 mg Oral
Subject Olmesartan medoxomil Unknown 40 mg Oral

Indications

No indication recorded.